BRADLEY HURLIMAN: Open Payments
NPI 1144357740 · WEST LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 98 payments from 11 companies in 2025. Trend: 2023 $1,428 · 2024 $1,762 · 2025 $1,530
Food & beverage: $1,430Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $439 |
| Novartis Pharmaceuticals Corporation | 34 | $375 |
| GENZYME CORPORATION | 6 | $179 |
| ABBVIE INC. | 21 | $171 |
| LEO Pharma Inc. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| UCB, Inc. | 3 | $61 |
| Lilly USA, LLC | 2 | $46 |
| Incyte Corporation | 2 | $43 |
| PFIZER INC. | 2 | $36 |
Products named: TREMFYA, COSENTYX, DUPIXENT, SKYRIZI, Bimzelx, ADBRY, ANZUPGO, TALTZ.
Industry payments across IN — which companies pay providers there.
